FDA
-
-
-
-
-
-
-
Bristol Myers Squibb Announces Positive Topline Results from the Interim Analysis of Phase 3 ACTION-1 for RYZ101, RayzeBio’s Radiopharmaceutical Therapy, in Patients with GEP-NETs
-
-
-
-
-
-
-
BMS presents five-year Camzyos data for heart condition at ESC
-
-
-
-
-
-
-
FDA accepts Bristol Myers Squibb's mezigdomide application for myeloma
-
-
-
-
-
-
-
Bristol Myers Squibb gets EU approval for Sotyktu to treat psoriatic arthritis
-
-
-
-
-
-
-
Bristol Myers Squibb wins FDA and EU approvals for Opdivo in Hodgkin lymphoma
-
-
-
-
-
-
-
FDA accepts Bristol Myers Squibb drug application for multiple myeloma
-
-
-
-
-
-
-
Bristol Myers Squibb partners with Microsoft on AI lung cancer detection
-
336,483 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


